Oxidative stress in patients with chronic kidney disease
- Conditions
- Renal Chronic kidney disease, Cardiovascular diseaseUrological and Genital DiseasesChronic kidney disease
- Registration Number
- ISRCTN31272864
- Lead Sponsor
- HS Greater Glasgow and Clyde (UK)
- Brief Summary
1. 2018 results in https://www.ncbi.nlm.nih.gov/pubmed/30094018 (added 22/01/2019)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
1. Aged over 18 years
2. Written informed consent
3. CKD - patients with chronic kidney disease recruited from local clinic. eGFR 15 - 30ml/min on recent bloods.
4. ESRD - patients with end stage renal disease recruited from local service. Currently receiving renal replacement therapy
5. HTN - patients with hypertension recruited from local clinic. Normal renal function but diagnosis of hypertension
1. Known liver disease (alcoholic liver disease, hepatitis, cirrhosis)
2. Known HIV infection
3. Known i.v. drug or alcohol abuse
4. Clinical signs of acute infection
5. Known pregnancy
6. Women of childbearing age are who are at risk of pregnancy
7. Subjects with a history of kidney stones
8. Subjects taking daily vitamin C supplements
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in flow mediated dilatation assessed by brachial artery ultrasound, after saline and after ascorbic acid
- Secondary Outcome Measures
Name Time Method <br> 1. Arterial stiffness assessed by pulse wave analysis using the Sphygmocor system.<br> 2. Biomarkers of oxidative stress both measured after saline and then at 0 and 60 minutes after ascorbic acid:<br> 2.1 Total antioxidant capacity measured by colorimetric assay<br> 2.2 Rate of reactive oxygen species generation measured by electron paramagnetic resonance<br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.